Corium’s Adlarity receives FDA nod for Alzheimer’s..

created a new article

1 y - Translate

Corium’s Adlarity receives FDA nod for Alzheimer’s, but faces a crowded market | #cholinesterase Drugs Development market

Corium’s Adlarity receives FDA nod for Alzheimer’s, but faces a crowded market

Corium’s Adlarity receives FDA nod for Alzheimer’s, but faces a crowded market

On 14 Walk, Corium reported that Adlarity (donepezil hydrochloride) had gotten FDA endorsement as a treatment for patients with gentle, moderate or extreme dementia of Alzheimer's infection (Promotion).

Like

Comment

Share